0
Special Feature |

Pathological Case of the Month FREE

[+] Author Affiliations

Section Editor: Enid Gilbert-barnes, MD

More Author Information
Arch Pediatr Adolesc Med. 1998;152(6):604. doi:.
Text Size: A A A
Published online

DIAGNOSIS AND DISCUSSION: ERYTHROPOIETIC PROTOPORPHYRIA

Figure 1. Dorsal hands of the patient, demonstrating the leathery, aged appearance.

Figure 2. Eosinophilic, homogeneous periodic acid–Schiff-positive material around blood vessels in the papillary dermis (original magnification ×25).

Figure 3. Higher-power view demonstrating perivascular distribution of the periodic acid–Schiff-positive material (original magnification ×50).

Erythropoietic protoporphyria (EPP) is an autosomal dominant disorder of variable expressivity that usually presents between the ages of 2 and 5 years with complaints of burning, stinging, or itching of sun-exposed skin.1 There may be edematous, erythematous plaques or rare papulovesicular lesions. Chronic changes of the skin include dyspigmentation, papular thickening, or hyperkeratosis of the skin of the dorsal hands, shallow pitted or linear scars of the face (especially the nose), and linear furrows around the lips. Systemic symptoms are often absent but may include cholecystitis or cholelithiasis, hypersplenism, and rarely hepatic failure due to portal and periportal fibrosis.

The disease results from a congenital abnormality in the enzyme ferrochelatase, which is necessary for the biosynthesis of heme. The resultant accumulation of the heme precursor, protoporphyrin IX in the red blood cells, liver, bone marrow, and plasma leads to the photosensitivity and systemic symptoms described earlier. The protoporphyrin level in the serum and red blood cells is markedly elevated in patients with EPP, and diagnosis can be made by measuring the level of this protoporphyrin in the serum or erythrocytes.2 The route of elimination of protoporphyrin is via the feces; thus, one may also measure fecal protoporphyrin levels to confirm a diagnosis of EPP. The large protoporphyrin molecule is poorly soluble in water, therefore, unlike other types of porphyria, the urine porphyrin levels are normal in EPP.

Histological features of EPP are distinctive. In the sun-exposed areas of skin, there is marked thickening of the blood vessel walls in the papillary dermis. The blood vessels are surrounded by an eosinophilic, homogenized material that is periodic acid–Schiff-positive and diastase resistant (Figure 2 and Figure 3). Immunofluorescence studies have shown this material to be type IV collagen, consistent with reduplication of the perivascular basal lamina.3

Treatment consists of vigorous photoprotection, especially to UV-A radiation, as the protoporphyrin molecule photosensitizing affinity falls in the UV-A (400- to 410-nm) range. Patients should avoid sunlight, especially midday, whenever possible. Additional photoprotection should include use of UV-A–blocking sunscreens such as titanium oxide or zinc oxide.4 Protective clothing should also be worn. Since UV-A light is not filtered by ordinary window glass, patients are not fully protected even while indoors. Some florescent and incandescent indoor light sources also emit UV-A radiation and may cause problems for patients with EPP.

Beta-carotene (Solatene, Hoffman-LaRoche, Nutley, NJ), a natural constituent of several plant sources (ie, carrots, tomatoes, and oranges), has been used with benefit in patients with EPP. Cholestyramine may also encourage fecal protoporphyrin elimination.

Accepted for publication April 1, 1997.

The opinions and assertions contained herein are the private ones of the authors and are not to be construed as official or reflecting the views of the Department of Defense or the US Army.

Corresponding author: MAJ Mary Mather, MC, USA, Dermatology Service, 1J, Walter Reed Army Medical Center, Washington, DC 20307.

Hurwitz  S Clinical Pediatric Dermatology. 2nd ed. Philadelphia, Pa WB Saunders Co1993;98- 99
Poh-Fitzpatrick  MB The erythropoietic porphyrias. Dermatol Clin. 1986;2291- 296
Murphy  GMHawk  JLMagnus  IA Late-onset erythropoietic protoporphyria with unusual cutaneous features. Arch Dermatol. 1985;1211309- 1312
Harber  LCBickers  DR Photosensitivity Diseases: Principles of Diagnosis and Treatment. 2nd ed. Toronto, Ontario BC Decker Inc1989;254- 263

Tables

References

Hurwitz  S Clinical Pediatric Dermatology. 2nd ed. Philadelphia, Pa WB Saunders Co1993;98- 99
Poh-Fitzpatrick  MB The erythropoietic porphyrias. Dermatol Clin. 1986;2291- 296
Murphy  GMHawk  JLMagnus  IA Late-onset erythropoietic protoporphyria with unusual cutaneous features. Arch Dermatol. 1985;1211309- 1312
Harber  LCBickers  DR Photosensitivity Diseases: Principles of Diagnosis and Treatment. 2nd ed. Toronto, Ontario BC Decker Inc1989;254- 263

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles